Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // February 25th, 2010 // 8:03 am
Hello, everyone. Have your shovel ready? Once again, a big storm is descending on the Pharmalot corporate campus and other parts of the Northeast. Nonetheless, we are not deterred. There is much to do. So here are a few items to help you keep focused. Dig in and, then, dig out…
Mylan Labs Posts Higher Profit (Associated Press)
Anadys Hep C Drugs Shows Early 73 Percent Response (Reuters)
Pfizer Wins Prempro Lawsuit (Philadelphia Inquirer)
Biotechs Turn To US CMOs (OutsourcingPharma)
Pfizer Osteoporosis Drug Gets Lukewarm Review (Reuters)
FDA OKs Pfizer’s Prevnar 13 Vaccine (Associated Press)
Shire Gets Fast-Track Status For Replagal (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Anadys, CMO, Contract Manufacturing Organizations, Mylan Laboratories, Pfizer, Prempro, Prevnar 13, Replagal, Shire Pharmaceuticals